|
More than 150 antiretroviral drugs available through PEPFAR for worldwide HIV/AIDS relief
|
24 July 2012 |
|
FDA approves generic versions of blood thinner Plavix
|
21 May 2012 |
|
FDA issues alert on potential dangers of unproven treatment for multiple sclerosis
|
11 May 2012 |
|
FDA approves first Boniva generics to treat or prevent osteoporosis
|
19 March 2012 |
|
FDA announces safety changes in labeling for some cholesterol-lowering drugs
|
28 February 2012 |
|
FDA acts to bolster supply of critically needed cancer drugs
|
22 February 2012 |
|
FDA approves first generic version of cholesterol-lowering drug Lipitor
|
01 December 2011 |
|
Drug not Shown to be Safe and Effective in Breast Cancer Patients
|
21 November 2011 |
|
FDA begins process to remove breast cancer indication from Avastin label
|
16 December 2010 |
|
FDA warns consumers not to use Vigor-25
|
21 November 2010 |
|
FDA: Include warnings on risk for class of prostate cancer drugs
|
25 October 2010 |
|
FDA: Possible increased risk of thigh bone fracture with bisphosphonates
|
14 October 2010 |
|
FDA issues final rule on safety information during clinical trials
|
29 September 2010 |
|
Forest Pharmaceuticals agrees to guilty plea for violating FDA laws
|
16 September 2010 |
|
FDA Proposes Withdrawal of Low Blood Pressure Drug
|
17 August 2010 |
|
FDA to Communicate Safety Monitoring Activities to Consumers and Health Care Professionals
|
16 June 2010 |
|
FDA: Rare Cases of Liver Injury Reported with Use of Xenical, Alli
|
27 May 2010 |
|
FDA Announces Collaboration with Drugs.com
|
27 May 2010 |
|
'Bad Ad Program' to Help Health Care Providers Detect, Report Misleading Drug Ads
|
14 May 2010 |
|
FDA Requests $4.03 Billion to Promote and Protect Public Health
|
03 February 2010 |